912
Views
14
CrossRef citations to date
0
Altmetric
AUTHOR'S VIEW

Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients

, , &
Article: e970032 | Received 21 Sep 2014, Accepted 23 Sep 2014, Published online: 10 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ruochuan Zang, Yuan Li, Runsen Jin, Xinfeng Wang, Yuanyuan Lei, Yun Che, Zhiliang Lu, Shuangshuang Mao, Jianbing Huang, Chengming Liu, Sufei Zheng, Fang Zhou, Qian Wu, Shugeng Gao, Nan Sun & Jie He. (2019) Enhancement of diagnostic performance in lung cancers by combining CEA and CA125 with autoantibodies detection. OncoImmunology 8:10.
Read now
Hans A. Schlößer, Martin Thelen, Axel Lechner, Kerstin Wennhold, Maria A. Garcia-Marquez, Sacha I. Rothschild, Elena Staib, Thomas Zander, Dirk Beutner, Birgit Gathof, Ramona Gilles, Engin Cukuroglu, Jonathan Göke, Alexander Shimabukuro-Vornhagen, Uta Drebber, Alexander Quaas, Christiane J. Bruns, Arnulf H. Hölscher & Michael S. Von Bergwelt-Baildon. (2019) B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies. OncoImmunology 8:1.
Read now

Articles from other publishers (12)

Ai Miyamoto, Tomoko Honjo, Mirei Masui, Rie Kinoshita, Hiromi Kumon, Kazuhiro Kakimi & Junichiro Futami. (2022) Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading. Frontiers in Oncology 12.
Crossref
Jessica Da Gama Duarte, Katherine Woods, Luke T. Quigley, Cyril Deceneux, Candani Tutuka, Tom Witkowski, Simone Ostrouska, Chris Hudson, Simon Chang-Hao Tsao, Anupama Pasam, Alexander Dobrovic, Jonathan M. Blackburn, Jonathan Cebon & Andreas Behren. (2021) Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses. Cancers 13:8, pages 1805.
Crossref
Maliheh Astaneh, Sepideh Dashti & Zahra Taherian Esfahani. (2019) Humoral immune responses against cancer-testis antigens in human malignancies. Human Antibodies 27:4, pages 237-240.
Crossref
Martin Sebastian, Andreas Schröder, Birgit Scheel, Henoch S. Hong, Anke Muth, Lotta von Boehmer, Alfred Zippelius, Frank Mayer, Martin Reck, Djordje Atanackovic, Michael Thomas, Folker Schneller, Jan Stöhlmacher, Helga Bernhard, Andreas Gröschel, Thomas Lander, Jochen Probst, Tanja Strack, Volker Wiegand, Ulrike Gnad-Vogt, Karl-Josef Kallen, Ingmar Hoerr, Florian von der Muelbe, Mariola Fotin-Mleczek, Alexander Knuth & Sven D. Koch. (2019) A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. Cancer Immunology, Immunotherapy 68:5, pages 799-812.
Crossref
Jan Kraśko, Karolina Žilionytė, Adas Darinskas, Neringa Dobrovolskienė, Agata Mlynska, Svetlana Riabceva, Iosif Zalutsky, Marina Derevyanko, Vladimir Kulchitsky, Olga Karaman, Natalia Fedosova, Tatiana Symchych, Gennady Didenko, Vasyl Chekhun, Marius Strioga & Vita Pašukonienė. (2018) Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model. Oncology Letters.
Crossref
Jean-François Baurain, Caroline Robert, Laurent Mortier, Bart Neyns, Florent Grange, Céleste Lebbe, Fernando Ulloa-Montoya, Pedro Miguel De Sousa Alves, Marc Gillet, Jamila Louahed, Silvija Jarnjak & Frédéric F Lehmann. (2018) Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic. ESMO Open 3:5, pages e000384.
Crossref
Sacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, Marcus O. Butler, Mary L. Disis, Jérôme Galon, Leif G. Hakansson, Brent A. Hanks, Vaios Karanikas, Samir N. Khleif, John M. Kirkwood, Lance D. Miller, Dolores J. Schendel, Isabelle Tanneau, Jon M. Wigginton & Lisa H. Butterfield. (2017) Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Zhen Zhang, Fan-Fan Li, Ming-Dian Lu, Shang-Xin Zhang & Yong-Xiang Li. (2017) Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma. Oncotarget 8:61, pages 103283-103289.
Crossref
Vandeclecio Lira da Silva, André Faustino Fonseca, Marbella Fonseca, Thayna Emilia da Silva, Ana Carolina Coelho, José Eduardo Kroll, Jorge Estefano Santana de Souza, Beatriz Stransky, Gustavo Antonio de Souza & Sandro José de Souza. (2017) Genome-wide identification of cancer/testis genes and their association with prognosis in a pan-cancer analysis. Oncotarget 8:54, pages 92966-92977.
Crossref
Yongfei Li, Jun Li, Yifan Wang, Yanhong Zhang, Jiahui Chu, Chunxiao Sun, Ziyi Fu, Yi Huang, Hansheng Zhang, Hongyan Yuan & Yongmei Yin. (2017) Roles of cancer/testis antigens (CTAs) in breast cancer. Cancer Letters 399, pages 64-73.
Crossref
Xu Lu, Lin Yang, Daxing Yao, Xuan Wu, Jingpo Li, Xuesong Liu, Lijuan Deng, Caiting Huang, Yue Wang, Dan Li & Jingwei Liu. (2017) Tumor antigen-specific CD8+ T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer. Cellular Immunology 313, pages 43-51.
Crossref
Yoshihiro Ohue, Koji Kurose, Ryohei Nozawa, Midori Isobe, Yumi Nishio, Tomonori Tanaka, Yoshinori Doki, Takashi Hori, Junya Fukuoka, Mikio Oka & Eiichi Nakayama. (2016) Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells. Cancer Immunology Research 4:12, pages 1049-1060.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.